Variant · Snv
RAD51D R186*
CI-VAR-00003742Explore in graph →ClinVar 30285 CIViC 471 rs387906843
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 25445424
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Malignant Breast Neoplasm1 | ||||||||
| RAD51D R186* | (predisposing) | Predisposing | C | N/A N/A | 2 | accepted | EID1111A healthy, 36-year-old woman presented with a palpable right breast mass upon biopsy determined to be high-grade, triple negative invasive ductal carcinoma. Her family history was notable for multiple… (full text at CIViC) PMID 25445424 · Baker et al., 2015 · Open in CIViC | civic |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 30285 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Breast-ovarian cancer, familial, susceptibility to, 4; Hereditary cancer-predisposing syndrome; Hereditary breast ovarian cancer syndrome; Breast and/or ovarian cancer; Malignant tumor of breast; Ovarian neoplasm; Inherited breast cancer and ovarian cancer; Inherited ovarian cancer (without breast cancer); Polycystic kidney disease 2; RAD51D-related disorder |